By Drug Target Review2025-12-04T08:30:48
Researchers at LMU Munich have developed Bits2Bonds, the first platform to fuse molecular simulations with machine learning – accelerating the discovery of polymer carriers for therapeutic RNA.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-06-29T09:19:53
Sponsored by BMG Labtech GmbH
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
2023-01-06T10:25:33
Sponsored by Leica Microsystems
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2024-02-06T08:57:06
Sponsored by bit.bio
Site powered by Webvision Cloud